Norway is leading the world in electric vehicle adoption. The most popular new car in Norway is outselling every rival in America. Norway leads the world in electric vehicle adoption, followed by ...

Forbes contributors publish independent expert analyses and insights. Cortney is an expert in smartglasses, VR, AI, and the future of work. LAS VEGAS, NEVADA - JANUARY 04: TCL Mobile Chief Marketing ...

Volkswagen has a fresh lineup with a facelifted Golf, Jetta, and Taos. If that wasn’t enough new blood, the company launched a redesigned Tiguan not long ago. While you’d expect these models to help ...

The Research and Economic Development department is leading a project to enhance UB’s alignment with the Cybersecurity Maturity Model Certification (CMMC) standards. Building on insights from a ...

Pharma marketers enter 2026 asking where DTC fits in the DTP era. That question, which few foresaw 12 months ago, reflects the fast rise of direct-to-patient (DTP) programs. In the last few months ...

Tesla is one of the most innovative automakers on the market today. However, thanks to models like the Cybertruck, which isn't the best off-road vehicle, they're also one of the most criticized. But ...

New electric vehicle sales have been slowing in the U.S. in recent months. Following the end of the federal tax credit and some new models on hold or canceled altogether, most automakers are expected ...

The David Ellison-led studio questions whether the bidding has been "tilted" and suggests Netflix has been receiving more favorable treatment so far in the auction. By Alex Weprin, Erik Hayden In a ...

I recently had the opportunity to hear Kathleen Quinn Votaw, speaker, author, and HR expert, deliver a talk that stopped me in my tracks. Among her many insights, one stood out: Recruitment is a sales ...

Despite weak sales of the first iPhone Air, reports suggest Apple hasn’t cancelled its follow-up and is instead targeting a 2027 release. Positioned as a tech experiment, the device could influence ...

Pacira BioSciences (PCRX) edged higher by 0.4% after an investor pushed the company to explore a sale process. "Due to what we believe is management's unrelenting underperformance, out-of-control ...